Trial of Oral Melatonin in Elevated Blood Pressure

Status Not yet recruiting

Clinical Trial Summary

Since, lowering blood pressure (BP) in elevated blood pressure individuals represents an excellent opportunity to for primary prevention of hypertension (HTN). Therefore, it is planned to use a safe treatment option - oral melatonin supplementation - associated with lifestyle interventions according to the American college of cardiology/American heart association (ACC/AHA) 2013 guideline in elevated blood pressure individuals to mitigate systolic and diastolic BP and ultimately, to prevent the development of HTN.

Hypothesis:

Melatonin therapy can lower the systolic and diastolic BP of elevated blood pressure individuals Melatonin can attenuate levels of circulatory biomarkers of Hs- CRP, Cholesterol, LDL-c and triglyceride

Clinical Trial Description

Study design: Randomized controlled trial (RCT)

Study population: Elevated blood pressure individuals who present themselves at the outpatient clinics of Tehran Heart Centre(THC) , seeking blood pressure treatment and who have a systolic blood pressure of 120-129 mmHg or a diastolic blood pressure of =80 mmHg.

Treatment groups: Melatonin 3 mg versus placebo

sample size: 160 per group ( 320 overall)

Treatment allocation: After completing informed consent and prior to randomization, all participants undergo complete physical examination and laboratory test. Baseline levels of inflammatory biomarkers and pregnancy test (for women in reproductive age) will be performed. Sleep quality, actual sleep time, and sleep latency will be recorded.

Treatment plan: Three weeks melatonin 3 Mg or placebo one hour before bedtime has been planned. All of the melatonin and placebo capsules will be supplied from a single hospital pharmacy and free of charge to the participants. Melatonin and placebo capsules will be identical. Participants will receive a three weeks supply at the assignment time. Besides, all participants will receive a careful plan of adherence to a heart-healthy diet, regular exercise, instruction for avoidance of tobacco use and maintenance of a healthy body mass index (BMI) according to 2013ACC/ AHA guideline.

Follow up: Three weeks ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03764020
Study type	Interventional
Source	Tehran University of Medical Sciences
Contact	zinat Hatmi
Phone	+982164053219
Email	hatmizn@sina.tums.ac.ir
Status	Not yet recruiting
Phase	Phase 3
Start date	June 1, 2019
Completion date	December 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03626363` - Mindfulness and Neural Cardiovascular Control in Humans	N/A
Recruiting	`NCT05121337` - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension	N/A
Active, not recruiting	`NCT05062161` - Sleep Duration and Blood Pressure During Sleep	N/A
Completed	`NCT04953650` - Intermittent Fasting Towards Elevated Blood Pressure	N/A
Enrolling by invitation	`NCT06033417` - Walking and Blood Pressure in Older Adults With Respiratory Impairment.	N/A
Completed	`NCT03716960` - The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.	N/A
Completed	`NCT05533268` - Effect of Mental and Physical Training on Blood Pressure	N/A
Completed	`NCT05029427` - Effect of Oat Beta Glucan in Managing Blood Pressure	N/A
Recruiting	`NCT05370625` - To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Not yet recruiting	`NCT06376812` - No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women	N/A
Not yet recruiting	`NCT06348225` - Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure	N/A
Active, not recruiting	`NCT04766424` - Sleep Technology Intervention to Target Cardiometabolic Health	N/A
Recruiting	`NCT05297708` - Office, Home, and Ambulatory Blood Pressure
Completed	`NCT00869193` - Effect of Grape Seed Extract on Blood Pressure	N/A
Completed	`NCT04298944` - Association of Mood With Risk for Atherosclerosis
Recruiting	`NCT05397535` - Baduanjin Lower Elevated Blood PreSsure Study	N/A
Completed	`NCT05928676` - Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure	N/A
Suspended	`NCT03508739` - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition	Phase 3
Active, not recruiting	`NCT05469503` - Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Recruiting	`NCT05955040` - Treatment of Elevated Blood Pressures in Early Pregnancy	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Trial of Oral Melatonin in Elevated Blood Pressure — MRCTEBP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms